By Tech Edge Editorial Staff Tech Edge and Exec Edge are please to provide video coverage of the third annual Palm Beach CorpGov Forum, which was held on Nov. 8, featuring a full day of panels and fireside chats....

By Thomas S. Green Apollomics Inc. (Nasdaq: APLM) said it saw strong results from two clinical trials for Vebreltinib, designed to target non-small cell lung cancer and other advanced tumors. The trials showed that patients without co-occurring MET amplification had...

By Thomas S. Green The Duckhorn Portfolio, Inc. (NYSE: NAPA) said fiscal first quarter net income was $15.5 million, compared to $19.8 million in the prior year period. “We delivered a quarter at the high end of our expectations as...

By Thomas S. Green Vince Holding Corp. (NYSE: VNCE) said third quarter gross profit was $37.2 million, or 44.2% of net sales, compared to gross profit of $29.8 million, or 30.2% of net sales, in the third quarter of fiscal...

By Healthcare Edge Editorial Staff Octave Bioscience, Inc. said Founder William Hagstrom will become Chairman of the Board, while Doug Biehn is the new President and CEO. Mr. Biehn has over 20 years of experience in healthcare, building and scaling...

By Karen E. Roman reAlpha Tech Corp. (Nasdaq: AIRE), a real estate company focusing on the use of artificial intelligence for efficiency and sustainable growth, declared it will acquire Naamche, a technology company that develops AI-powered solutions for large industries...

By Exec Edge Editorial Staff Exec Edge spoke with Frantz Saintellemy, Incoming CEO of LeddarTech, which is going public via a merger with Prospector Capital Corp. (Nasdaq: PRSR). ExecEdge: Welcome, Frantz. Let’s start off by learning a little more about...

By John Jannarone of PE Edge Private-equity firm TZP Group has created a new star, investing in two of the industry’s top innovators to form DanceOne, marking the largest institutional dance investment in history while creating the world’s biggest dance...

By Thomas Green Bonaventure —an integrated alternative asset management firm with over $2.3 billion of assets under management— said it recently acquired a 121 unit Class-A multifamily community in downtown Norfolk, Va. with its perpetual life multifamily fund.  As part of...

    By Healthcare Edge Editorial Staff SAB Biotherapeutics, Inc. (Nasdaq: SABS), which is trying to slow down the progression of type 1 diabetes, said it started trials of SAB-142 on humans in Australia. SAB-142 is the first fully-human anti-thymocyte...